October 14th 2016

October 14, 2016

You Are All Amazing.

A huge thank-you again to everyone who donated to our "Control ALT, Delete Cancer" campaign, not just meeting the $60,000 fundraising goal but exceeding it by $12k! Your contributions make groundbreaking research possible and bring us that much closer to a world where cancer is nothing but a memory. The full list of donors is now online - click to view on our website. We are also starting to prepare your prizes for shipping, so contributors should check the mail for their T-shirts, tote bags, etc., over the next few weeks.

Those of you who donated at the $30 level and provided a picture representing a loved one who has battled cancer -- your photos have now been assembled into a "Faces of Cancer" wall. We look forward to a day when it becomes impossible to put together such a collage, but for now, we hope that this tribute to real, much-loved individuals can stand as a reminder of what is at stake in the context of programs like OncoSENS. 

Note: if you donated $30 but have not yet submitted a photo, it is not too late to do so! Please send the image of your choice, along with the name of the one you wish to honor and the type of cancer they have/had, to jerri.barrett@sens.org. 

Question of the Month 15: Would Other Rejuvenation Biotechnologies Keep Us Cancer-Free?

Q: SENSRF has backed a bold, long-term strategy to eliminate cancer. But cancer is very rare in young and early middle-aged adults. Might keeping the body young with other rejuvenation biotechnologies be enough to hold cancer at bay without the need for more intensive, specific approaches?

A: It’s certainly a good bet that applying rejuvenation biotechnologies to remove, repair, and replace other kinds of aging damage will in some ways make us less vulnerable to cancer. Notably, ablating senescent cells would eliminate the “senescence-associated secretory phenotype” (SASP), which promotes the growth and invasiveness of cancers in several ways, including stimulating early-stage cancer cells to continue replicating, encouraging the growth of new blood vessels needed by cancer cells to supply themselves with fuel and oxygen, and breaking down the physical barriers that prevent them from metastasizing, which is when most cancers become deadly. Also, rejuvenating the aging immune system (by eliminating the dysfunctional T-cells that accumulate with age and rebuilding the atrophied thymus gland) will restore the body’s ability to suss out and eliminate cancers as they emerge.

But it’s also clear that deploying these other rejuvenation biotechnlogies won’t be enough to eliminate cancer altogether, and that must be our ultimate goal. 

The "Question of the Month" column is your opportunity to submit your research-related queries to SRF's expert science writer Michael Rae. Please send your questions to foundation@sens.org and they may be featured in a future newsletter.

Support SRF While You Shop This Holiday Season with Amazon Smile

If you haven't already signed up for Amazon Smile, there is no better time than now. It's easy -- just visit SRF's unique Amazon Smile URL and verify that you want to support SENS Foundation Inc. when prompted. Using Amazon Smile means Amazon will donate 0.5% of the purchase price of whatever you buy to SRF at no additional cost to you. Help fight age-related disease this holiday season and throughout the year in one easy step.

Where in the World is Aubrey de Grey?

Aubrey de Grey will be speaking at the following events:

Where: New York, NY, USA
When: November 30, 2016, 6:30 PM - 9:30 PM

ScienceVest (YC Fellowship 3) is a fund and platform for hard-tech and life science companies. They help entreprpeneurs on their journey of changing the world through breakthrough science. This event will be "a discussion on the state of anti-aging technologies/science and how we can all fund the scientific breakthroughs that will make anti-aging technologies a reality."

Where: West Palm Beach, Florida, USA
When: December 6-9, 2016

The World Stem Cell Summit and RegMed Capital Conference is the original, translation-focused global meeting of stakeholders, now celebrating its 12th year. The WSCS brings together leading scientists and clinicians, investors, customers, legal experts, funders, regulators, and patients. Dr. Aubrey de Grey will speak on "Unleashing Regenerative Medicine to Extend the Healthy Lifespan: Technological Issues and Commercial Opportunities" on December 8, 9:30 am - 10:30 am.

 

 

Want to help spread the word about SRF's mission?

Share our vision to Reimagine Aging on

 

   Facebook       @SENSTweet

Please show your support for SRF's work - Donate Today.

As a 501(c)(3) public charity, SENS Research Foundation relies on your support

to continue our mission to change the way the world researches and treats age-related disease.

 

 

Visit our donate page to make your contribution.

 

Want your Amazon purchases to help fight age-related disease?

When you shop at AmazonSmile, Amazon donates 0.5% of the purchase price to SENS Research Foundation. Bookmark this link and support us every time you shop!